CIK 0000874716 · Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010393723
- Phone
- 2075560300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise | +483 | $206.94 | $100K | 14,712.35 |
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise | +183 | $544.08 | $100K | 14,895.35 |
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise | +197 | $505.53 | $100K | 15,092.35 |
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −719 | 0 | ||
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −817 | 0 | ||
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 | ||
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −183 | 0 | ||
| 2026-02-19 | Erickson Michael G Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −197 | 0 | ||
| 2026-02-17 | Erickson Michael G Executive Vice President | Option exercise | +1,191 | $141.60 | $169K | 13,884.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Option exercise | +4,180 | $178.26 | $745K | 18,064.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −456 | $623.76 | $284K | 17,608.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −204 | $625.24 | $128K | 17,404.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −1,288 | $626.26 | $807K | 16,116.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −2,694 | $628.22 | $1.7M | 13,422.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −689 | $629.09 | $433K | 12,733.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Sale | −40 | $629.86 | $25K | 12,693.35 |
| 2026-02-17 | Erickson Michael G Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,191 | 0 | ||
| 2026-02-17 | Erickson Michael G Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −4,180 | 0 | ||
| 2026-02-17 | Vandebroek Sophie V. Director | Option exercise | +945 | $333.90 | $316K | 2,112 |
| 2026-02-17 | Vandebroek Sophie V. Director | Sale | −945 | $628.65 | $594K | 1,167 |
Page 6 of 28 · 552 trades